This company has court orders or restrictions applied. This may indicate debt obligations or legal issues.
| Type | Details | Applied | Case number | Institution |
|---|---|---|---|---|
| Kommertspant 1 (active) | 80000.00 EUR; Holder: Swedbank AS | 2019. gada 27. marts | KP-11505401-1 | Swedbank AS |
| Kommertspant 2 (active) | 20000.00 EUR; Holder: Swedbank AS | 2020. gada 21. aprīlis | KP-11505401-2 | Swedbank AS |
| Kommertspant 3 (active) | 100000.00 EUR; Holder: Swedbank AS | 2021. gada 8. aprīlis | KP-11505401-3 | Swedbank AS |
| Kommertspant 4 (active) | 155000.00 EUR; Holder: Swedbank AS | 2022. gada 18. marts | KP-11505401-4 | Swedbank AS |
4 active commercial pledge(s) registered against this company.
| Amount | Priority | Pledge holder | Registered | Ends |
|---|---|---|---|---|
| 80 000 EUR | esimene | Swedbank AS | N/A | — |
| 20 000 EUR | teine | Swedbank AS | N/A | — |
| 155 000 EUR | neljas | Swedbank AS | N/A | — |
| 100 000 EUR | kolmas | Swedbank AS | 2021. gada 4. augusts | — |
Source: Estonian Business Register (ariregister.rik.ee).
Public-sector contracts won via EU procurement (TED).
| Buyer | Contract | Value | Date |
|---|---|---|---|
| Aktsiaselts Ida-Tallinna Keskhaigla | Raamleping_Globalex Pharma OÜ | €2094 | 2026. gada 23. februāris |
| Aktsiaselts Lääne-Tallinna Keskhaigla | MÜÜGILEPING nr 3-7/1804-1 | €10 000 | 2025. gada 20. janvāris |
| sihtasutus Tartu Ülikooli Kliinikum | RAVIMITE MÜÜGI RAAMLEPING 700 | €15 009 | 2025. gada 2. janvāris |
| sihtasutus Tartu Ülikooli Kliinikum | Raamleping 1 | €1 019 333 | 2024. gada 9. septembris |
| Aktsiaselts Ida-Tallinna Keskhaigla | Raamleping_B.Braun Medical OÜ | €12 220 | 2024. gada 8. februāris |
| year | 2026Latest | 2025 | 2024 |
|---|---|---|---|
Revenue | 0 € | 0 € -100.0% | 10,7m € +42.7% |
Profit | — | — -100.0% | 434,3k € +82.2% |
Assets | — | — -100.0% | 2,3m € +103.4% |
Liabilities | — | — -100.0% | 1,1m € +179.1% |
Equity | — | — -100.0% | 1,2m € +60.2% |
Employees | 5 +0.0% | 5 +25.0% | 4 +33.3% |
Overall rating | B65/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 85/100 |
Business activity | 60/100 |
| Overall risk | Medium |
Possible tax debts | |
Possible tax debts | |
Regular report filing | |
Positive equity | |
Can cover short-term debts | |
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 18 years | 79 - 83 | 59% | |
Registered capital | 2556,00 € | - | 10% |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - |
Globalex Pharma OÜ is located at Harju maakond, Tallinn, Kesklinna linnaosa, Pärnu mnt 31-45, 10119.
In 2026, Globalex Pharma OÜ had an average of 5 employees. View tax history →
The beneficial owners of Globalex Pharma OÜ are Ivari Saar, Jevgeni Stasjuk and Polina Stasjuk. View ownership details →
Yes, Globalex Pharma OÜ is registered as an active VAT payer with VAT number EE101258939.
In 2026, the average gross salary at Globalex Pharma OÜ was approximately 1006,87 € per month (net ~ 772,80 €). This is an approximate calculation. View salary details →
Globalex Pharma OÜ was founded on May 16, 2008. The company has been operating for 18 years.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| GLOBALEX HOLDING OÜ | - | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Ivari Saar | EE | - | |
| Jevgeni Stasjuk | EE | - | |
| Polina Stasjuk | EE | - |
Annual financial report for 2026.
Annual financial report for 2025.
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Estonian business register.